Contact

Safety and Immunogenicity of a Zika Purified Inactivated Virus Vaccine Given Via Standard, Accelerated, or Shortened Schedules: a Single-Centre, Double-Blind, Sequential-Group, Randomised, Placebo-Controlled, Phase 1 Trial

Kathryn E Stephenson et.al., The Lancet Infectious Diseases (2020) - PMID: n.a.

Product(s) used in this publication: PepMix™ Peptide Pools

Abstract

n.a.

Stay in touch and be the first to receive the latest news!